News

Filter

Current filters:

None

73 to 82 of 97249 results

New guidance provides optimism for securing life sciences patents in USA

New guidance provides optimism for securing life sciences patents in USA

17-12-2014

The US Patent and Trademark Office (USPTO) has released its 2014 Interim Guidance on Patent Subject Matter…

PatentsPharmaceuticalPrometheus LabsUS Patent and Trademark OfficeUSA

FDA approves Ipsen's Somatuline for metastatic gastroentero pancreatic neuroendocrine tumors

FDA approves Ipsen's Somatuline for metastatic gastroentero pancreatic neuroendocrine tumors

17-12-2014

The US Food and Drug Administration has approved Somatuline Depot (lanreotide) injection 120mg, manufactured…

IpsenOncologyPharmaceuticalRegulationSomatulineUSA

Top 30 Pharmas spent $112 billion on R&D in 2013; report

Top 30 Pharmas spent $112 billion on R&D in 2013; report

17-12-2014

The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development…

FinancialGlobalGlobalDataJohnson & JohnsonNovartisPfizerPharmaceuticalPharmaceutical sciencesResearch

UCB, Advent and Avista Capital terminate $1.5 billion divestment agreement

UCB, Advent and Avista Capital terminate $1.5 billion divestment agreement

17-12-2014

Belgian drugmaker UCB and private equity firms Avista Capital and Advent International have mutually…

BelgiumBusiness FinanceConcertaGenericsUCB

Janssen returns rights of IBD drug GLPG1205 to Galapagos

Janssen returns rights of IBD drug GLPG1205 to Galapagos

17-12-2014

US health care giant Johnson & Johnson’s Europe-based subsidiary Janssen has returned the rights to…

GalapagosGastro-intestinalsJanssenJanssen PharmaceuticaLicensingPharmaceutical

Novartis venture fund leads $34 million financing for Annexon Bioscience

Novartis venture fund leads $34 million financing for Annexon Bioscience

17-12-2014

USA-based Annexon Bioscience says it has closed a $34 million Series A-1 to support the development of…

Annexon BioscienceANX005BiotechnologyFinancialNeurologicalNovartis

Cyclacel shares fall as sapacitabine disappoints in Phase III acute myeloid leukemia trial

Cyclacel shares fall as sapacitabine disappoints in Phase III acute myeloid leukemia trial

17-12-2014

The announcement that Cyclacel Pharmaceuticals’ (Nasdaq: CYCC) Phase III trial of sapacitabine was…

CyclacelOncologyPharmaceuticalResearchsapacitabine

With buy of Veropharm, Abbott to significantly increase revenue in Russia

With buy of Veropharm, Abbott to significantly increase revenue in Russia

17-12-2014

US drugmaker Abbott plans to significantly increase its revenue in the Russian market over the next several…

AbbottFinancialGenericsMarkets & MarketingProductionRussiaVeropharm

New drug price cuts demonstrate Australian PBS sustainability

New drug price cuts demonstrate Australian PBS sustainability

17-12-2014

In Australia, price cuts to over 100 Pharmaceutical Benefits Scheme (PBS)-listed medicines that will…

AustraliaAustralian PBSHealthcarePharmaceuticalPricing

73 to 82 of 97249 results

Back to top